Order Article Reprints

Wang Y, Ding Y, Sun P, Zhang W, Xin Q, Wang N, Niu Y, Chen Y, Luo J, Lu J, et al. Empagliflozin-Enhanced Antioxidant Defense Attenuates Lipotoxicity and Protects Hepatocytes by Promoting FoxO3a- and Nrf2-Mediated Nuclear Translocation via the CAMKK2/AMPK Pathway. Antioxidants. 2022; 11(5):799. https://doi.org/10.3390/antiox11050799

Wang, Yangyang, Yipei Ding, Pengbo Sun, Wanqiu Zhang, Qilei Xin, Ningchao Wang, Yaoyun Niu, Yang Chen, Jingyi Luo, Jinghua Lu, and et al. 2022. "Empagliflozin-Enhanced Antioxidant Defense Attenuates Lipotoxicity and Protects Hepatocytes by Promoting FoxO3a- and Nrf2-Mediated Nuclear Translocation via the CAMKK2/AMPK Pathway" Antioxidants 11, no. 5: 799. https://doi.org/10.3390/antiox11050799

Wang, Y., Ding, Y., Sun, P., Zhang, W., Xin, Q., Wang, N., Niu, Y., Chen, Y., Luo, J., Lu, J., Zhou, J., Xu, N., Zhang, Y., & Xie, W. (2022). Empagliflozin-Enhanced Antioxidant Defense Attenuates Lipotoxicity and Protects Hepatocytes by Promoting FoxO3a- and Nrf2-Mediated Nuclear Translocation via the CAMKK2/AMPK Pathway. Antioxidants, 11(5), 799. https://doi.org/10.3390/antiox11050799